NextCure Inc. announced that Solomon Langermann, Ph.D., has resigned from his position as Chief Scientific Officer, effective September 1, 2025. The company confirmed that his resignation was not due to any disagreements related to company operations or policies.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-011752), on August 25, 2025, and is solely responsible for the information contained therein.